Development and in Vitro evaluatio n of thermorevesible nasal gel formulations of rizatriptan benzoate

Indian Journal of Pharmaceutical Education and Research

Volumn 43, Issue 1, 2009, Pages 55-62

  Praveen, Chaudhari ^a   Amit, Ajab ^a   Prashant, Malpure ^a   Pramod, Kolsure ^a   Devidas, Sanap ^a  

^a DR D Y PATIL INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

Locust bean gum; Poloxamer; Rizatriptan benzoate; Xanthan gum

Indexed keywords

POLOXAMER; POLYMER; RIZATRIPTAN; XANTHAN;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG STABILITY; GEL; GELATION; HUMAN; IN VITRO STUDY; NONHUMAN; PATIENT COMPLIANCE; SUSTAINED DRUG RELEASE; TEMPERATURE; THERMOSTABILITY;

EID: 69949087667     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Choi HK, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK. Development of in situ gelling and mucoadhesive acetaminophen liquid suppository. Int. J. Pharm. 1998, 165, 33-44.
2. Varsha Agarwal, B Mishra. Recent trends in drug delivery systems: Intranasal drug delivery, Indian journal of Experimental biology Jan.1999 Vol.37, 6-16.
3. Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA. Lines C (1998) The rizatriptan protocol 046 study group crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 in migraine. Headache 38,737-747.
4. Singhare DS, Khan S, Yeole PG. Poloxamers: Promosing block co-polymers in drug delivery, Ind. J.Pharm. Sci. 2005, sept - oct., 523 - 531.
5. BASF Wyandotte, Pluronic surfactants, Product Brochure BASF Corporation, Mount olive, New Jersey, 1997.
6. Collectt JH, Davies MC. Effect of batch variability on molecular properties and in- vivo release characteristics of pluronic PF-127 gels, J. Pharm. Pharmacology, 1984, 36, 52-57.
7. Tomida H, Shinohara M, Kuwada N, Kiryn S. Invitro release characteristics of diclofenac and hydrocortisone from pluronic F-127 gels, Acta Pharm Suec., 1987, 24, 263-272.
8. Ryu J, Chung S, Lee M, Kim C, Shim C. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum. Int. J. Pharm. 1999, 59,163-172.
9. Desai SD, Blanchard J. In-vitro evaluation of pluronic F-127 based controlled ocular delivery systems for pilocarpine, J. Pharm. Sci., 1998, 87, 226-230.
10. Pec EA, Wout ZG, Johnston TP. Biological activity of urease formulated in poloxamer 407 after intraperitonieal injection in the rat. J.Pharm. Sci. 1992, 81, 626-630.
11. Morikkawa K, Okada F, Hosokawa M, Kobayashi H. Enhancement of the of therapeutic effects of recombinantt interleukin-2 on a transplantable rat fibrosarcoma by the use of a sustained release vehical pluronic gel. Cancer Res., 1987, 47, 37-41.
12. Suh H, Jun HW, Dzimianski MT. Pharmacokinetic and local tissue deposition studies of naproxen following topical and systemic administration in dogs and rats. Biopharm. Drug Dispos. 1997, 18,623-633.
13. Stratton LP, Dong A, Manning MC, Carpenter JF. Drug delivery matrix containing native protein precipitate suspending in a poloxamer gel. J.Pharm. Sci., 1997, 86, 1006-1010.
14. Schmolka IR. Prepratiopn and properties of Pluronic PF-127 gels for the treatment of burns, J. Biomed. Mater. Res.1972, 6,571-582.
15. Miller SC, and Donovan MD. Effect of poloxamer 407 gels on the miotic activity of pilocarpine nitrate in rabbits, Int. J. Pharm., 1982, 142-152.
16. Yong CS, Choi JS, Quan QZ, Rhee JD, Kim CK et al. Effect of sodium chloride on gelation temperature temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium., Int. J. Pharm., 2001, 226, 195- 205.
17. Pisal SS, Reddy P, Paradkar AK, Mahadik KR, Kadam SS. Nasal melatonin gels using pluronic PF-127 for chronobiological treatment of sleep disorder, Indian J. Biotech. 2004, 3, 369-377.
18. Nahed D, Mordata Seham S, Abd elhady Gehanne AS. Development of in-situ gelling and mucoadhesive mebeverine hydrochloride solution for rectal administration, Saudi pharma. Journal, 2003, 11(4), 159-171.
19. Jeong B, Kim S, Bae Y. Thermoreversible sol-gel hydrogels. Adv. Drug Deliv. Rev. 2002, 54, 37-51.
20. Ahuja A, Khar RK, and Ali J. Mucoadhesive drug delivery systems. Drug Dev.Ind. Pharm. 1977, 23,489-515.